These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3183633)

  • 1. Effects of long-term acyclovir chemosuppression on serum IgG antibody to herpes simplex virus.
    Erlich KS; Hauer L; Mills J
    J Med Virol; 1988 Sep; 26(1):33-9. PubMed ID: 3183633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic-dose acyclovir to suppress frequently recurring genital herpes simplex virus infection: effect on antibody response to herpes simplex virus type 2 proteins.
    Gold D; Ashley R; Solberg G; Abbo H; Corey L
    J Infect Dis; 1988 Dec; 158(6):1227-34. PubMed ID: 2848900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological assessment of acyclovir treatment of herpes genitalis.
    Ragab NF; Habib MA; Ghozzi MY
    Arch Androl; 1989; 23(2):147-53. PubMed ID: 2556084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class-specific antibody response in acyclovir-treated and adenine arabinoside-treated patients with primary genital herpes simplex virus infection.
    Kawana T; Hashido M; Koizumi Y
    Microbiol Immunol; 1995; 39(10):795-9. PubMed ID: 8577270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus.
    Ashley RL; Corey L
    J Clin Invest; 1984 Mar; 73(3):681-8. PubMed ID: 6323525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir.
    Corey L; Mindel A; Fife KH; Sutherland S; Benedetti J; Adler MW
    Sex Transm Dis; 1985; 12(4):215-8. PubMed ID: 3001952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir.
    Bernstein DI; Stanberry LR; Harrison CJ; Kappes JC; Myers MG
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1601-12. PubMed ID: 3016155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status and prospects for oral acyclovir treatment of first episode and recurrent genital herpes simplex virus.
    Bryson YJ
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():61-5. PubMed ID: 6355052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of the effects of acyclovir treatment on the HSV-2 lymphoproliferative response of persons with frequently recurring HSV-2 genital infections.
    Frenkel L; Pineda E; Garratty E; Fall H; Dillon M; Bryson Y
    J Infect Dis; 1989 May; 159(5):845-50. PubMed ID: 2540245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year acyclovir suppression of frequently recurring genital herpes: a study of efficacy, safety, virus sensitivity and antibody response.
    Molin L; Ruhnek-Forsbeck M; Svennerholm B
    Scand J Infect Dis Suppl; 1991; 80():33-9. PubMed ID: 1666444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections.
    Bernstein DI; Lovett MA; Bryson YJ
    J Infect Dis; 1984 Jul; 150(1):7-13. PubMed ID: 6086772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to herpes simplex virus glycoprotein D: effects of acyclovir and relation to recurrence.
    Bernstein DI; Stanberry LR; Harrison CJ; Shukla R; Kappes JC; Myers MG
    J Infect Dis; 1987 Sep; 156(3):423-9. PubMed ID: 3039009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes.
    Mattison HR; Reichman RC; Benedetti J; Bolgiano D; Davis LG; Bailey-Farchione A; Remington M; Winter C; Corey L
    Am J Med; 1988 Aug; 85(2A):20-5. PubMed ID: 3044086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.
    Wald A; Corey L; Cone R; Hobson A; Davis G; Zeh J
    J Clin Invest; 1997 Mar; 99(5):1092-7. PubMed ID: 9062368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrences after first episodes of genital herpes in patients treated with topical acyclovir cream.
    Barton IG; Kinghorn GR; Rowland M; Jeavons M; Al-Omer LS; Potter CW
    Antiviral Res; 1984 Oct; 4(5):293-300. PubMed ID: 6517563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of systemic acyclovir treatment of genital HSV-2 infections on antibody responses to individual HSV-2 proteins.
    Ashley R; Mack K; Critchlow C; Shurtleff M; Corey L
    J Med Virol; 1988 Mar; 24(3):309-19. PubMed ID: 2835427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir in first attacks of genital herpes and prevention of recurrences.
    Mindel A; Weller IV; Faherty A; Sutherland S; Fiddian AP; Adler MW
    Genitourin Med; 1986 Feb; 62(1):28-32. PubMed ID: 3512419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial.
    Peacock JE; Kaplowitz LG; Sparling PF; Durack DT; Gnann JW; Whitley RJ; Lovett M; Bryson YJ; Klein RJ; Friedman-Kien AE
    Am J Med; 1988 Sep; 85(3):301-6. PubMed ID: 3046350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.